CpG-Methylation Regulates a Class of Epstein-Barr Virus Promoters
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian gene regulation. In general, cytosine-phosphatidyl-guanosine (CpG)-methylated promoters are transcriptionally repressed and nuclear proteins such as MECP2, MBD1, MBD2, and MBD4 bind CpG-methylated DNA and contribute to epigenetic silencing. Methylation of viral DNA also regulates gene expression of Epstein-Barr virus (EBV), which is a model of herpes virus latency. In latently infected human B cells, the viral DNA is CpG-methylated, the majority of viral genes is repressed and virus synthesis is therefore abrogated. EBV's BZLF1 encodes a transcription factor of the AP-1 family (Zta) and is the master gene to overcome viral gene repression. In a genome-wide screen, we now identify and characterize those viral genes, which Zta regulates. Among them are genes essential for EBV's lytic phase, which paradoxically depend on strictly CpG-methylated promoters for their Zta-induced expression. We identified novel DNA recognition motifs, termed meZRE (methyl-Zta-responsive element), which Zta selectively binds in order to ‘read’ DNA in a methylation- and sequence-dependent manner unlike any other known protein. Zta is a homodimer but its binding characteristics to meZREs suggest a sequential, non-palindromic and bipartite DNA recognition element, which confers superior DNA binding compared to CpG-free ZREs. Our findings indicate that Zta has evolved to transactivate cytosine-methylated, hence repressed, silent promoters as a rule to overcome epigenetic silencing.
Vyšlo v časopise:
CpG-Methylation Regulates a Class of Epstein-Barr Virus Promoters. PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001114
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001114
Souhrn
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian gene regulation. In general, cytosine-phosphatidyl-guanosine (CpG)-methylated promoters are transcriptionally repressed and nuclear proteins such as MECP2, MBD1, MBD2, and MBD4 bind CpG-methylated DNA and contribute to epigenetic silencing. Methylation of viral DNA also regulates gene expression of Epstein-Barr virus (EBV), which is a model of herpes virus latency. In latently infected human B cells, the viral DNA is CpG-methylated, the majority of viral genes is repressed and virus synthesis is therefore abrogated. EBV's BZLF1 encodes a transcription factor of the AP-1 family (Zta) and is the master gene to overcome viral gene repression. In a genome-wide screen, we now identify and characterize those viral genes, which Zta regulates. Among them are genes essential for EBV's lytic phase, which paradoxically depend on strictly CpG-methylated promoters for their Zta-induced expression. We identified novel DNA recognition motifs, termed meZRE (methyl-Zta-responsive element), which Zta selectively binds in order to ‘read’ DNA in a methylation- and sequence-dependent manner unlike any other known protein. Zta is a homodimer but its binding characteristics to meZREs suggest a sequential, non-palindromic and bipartite DNA recognition element, which confers superior DNA binding compared to CpG-free ZREs. Our findings indicate that Zta has evolved to transactivate cytosine-methylated, hence repressed, silent promoters as a rule to overcome epigenetic silencing.
Zdroje
1. MaatoukDM
KellamLD
MannMR
LeiH
LiE
2006 DNA methylation is a primary mechanism for silencing postmigratory primordial germ cell genes in both germ cell and somatic cell lineages. Development 133 3411 3418
2. MohnF
WeberM
RebhanM
RoloffTC
RichterJ
2008 Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 30 755 766
3. KallaM
SchmeinckA
BergbauerM
PichD
HammerschmidtW
2010 AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc Natl Acad Sci U S A 107 850 855
4. KieffE
RickinsonAB
2007 Epstein-Barr virus and its replication.
KnipeDM
HowleyPM
GriffinDE
MartinMA
LambRA
RoizmanB
StrausSE
Fields Virology Philadelphia Lippincott - Williams & Wilkins 2603 2654
5. YoungLS
RickinsonAB
2004 Epstein-Barr virus: 40 years on. Nat Rev Cancer 4 757 768
6. TakadaK
ShimizuN
SakumaS
OnoY
1986 Transactivation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 57 1016 1022
7. CountrymanJ
JensonH
SeiblR
WolfH
MillerG
1987 Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol 61 3672 3679
8. SinclairAJ
2003 bZIP proteins of human gammaherpesviruses. J Gen Virol 84 1941 1949
9. FarrellPJ
RoweDT
RooneyCM
KouzaridesT
1989 Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J 8 127 132
10. Chevallier-GrecoA
ManetE
ChavrierP
MosnierC
DaillieJ
1986 Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. Embo J 5 3243 3249
11. SchepersA
PichD
HammerschmidtW
1993 A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. Embo J 12 3921 3929
12. FeederleR
KostM
BaumannM
JanzA
DrouetE
2000 The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19 3080 3089
13. BhendePM
SeamanWT
DelecluseHJ
KenneySC
2004 The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat Genet 36 1099 1104
14. DickersonSJ
XingY
RobinsonAR
SeamanWT
GruffatH
2009 Methylation-dependent binding of the Epstein-Barr virus BZLF1 protein to viral promoters. PLoS Pathog 5 e1000356
15. KarlssonQH
SchelcherC
VerrallE
PetosaC
SinclairAJ
2008 Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein. PLoS Pathog 4 e1000005
16. SchaeferBC
StromingerJL
SpeckSH
1997 Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs. Mol Cell Biol 17 364 377
17. MinarovitsJ
2006 Epigenotypes of latent herpesvirus genomes. Curr Top Microbiol Immunol 310 61 80
18. DelecluseHJ
HilsendegenT
PichD
ZeidlerR
HammerschmidtW
1998 Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95 8245 8250
19. RothbauerU
ZolghadrK
MuyldermansS
SchepersA
CardosoMC
2008 A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol Cell Proteomics 7 282 289
20. BaerR
BankierAT
BigginMD
DeiningerPL
FarrellPJ
1984 DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310 207 211
21. UrierG
BuissonM
ChambardP
SergeantA
1989 The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EMBO J 8 1447 1453
22. LiebermanPM
HardwickJM
SampleJ
HaywardGS
HaywardSD
1990 The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J Virol 64 1143 1155
23. HammerschmidtW
SugdenB
1988 Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55 427 433
24. FlemingtonE
SpeckSH
1990 Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol 64 1227 1232
25. PackhamG
EconomouA
RooneyCM
RoweDT
FarrellPJ
1990 Structure and function of the Epstein-Barr virus BZLF1 protein. J Virol 64 2110 2116
26. BhendePM
SeamanWT
DelecluseHJ
KenneySC
2005 BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J Virol 79 7338 7348
27. KenneySC
Holley-GuthrieE
QuinlivanEB
GutschD
ZhangQ
1992 The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells. Mol Cell Biol 12 136 146
28. QuinlivanEB
Holley-GuthrieEA
NorrisM
GutschD
BachenheimerSL
1993 Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res 21 1999 2007
29. RooneyCM
RoweDT
RagotT
FarrellPJ
1989 The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol 63 3109 3116
30. GranatoM
FarinaA
GonnellaR
SantarelliR
FratiL
2006 Regulation of the expression of the Epstein-Barr virus early gene BFRF1. Virology 347 109 116
31. HungCH
LiuST
1999 Characterization of the Epstein-Barr virus BALF2 promoter. J Gen Virol 80 2747 2750
32. NakayamaS
MurataT
MurayamaK
YasuiY
SatoY
2009 Epstein-Barr Virus Polymerase Processivity Factor Enhances BALF2 Promoter Transcription as a Coactivator for the BZLF1 Immediate-Early Protein. J Biol Chem 284 21557 21568
33. FixmanED
HaywardGS
HaywardSD
1992 trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J Virol 66 5030 5039
34. GruffatH
BatisseJ
PichD
NeuhierlB
ManetE
2002 Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus. J Virol 76 9635 9644
35. JothiR
CuddapahS
BarskiA
CuiK
ZhaoK
2008 Genome-wide identification of in vivo protein-DNA binding sites from ChIP-Seq data. Nucleic Acids Res 36 5221 5231
36. BaileyTL
WilliamsN
MislehC
LiWW
2006 MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res 34 W369 73
37. ValouevA
JohnsonDS
SundquistA
MedinaC
AntonE
2008 Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data. Nat Methods 5 829 834
38. HeatherJ
FlowerK
IsaacS
SinclairAJ
2009 The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1. J Gen Virol 90 1450 1454
39. KlugM
RehliM
2006 Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics 1 127 130
40. BuissonM
ManetE
TrescolBM
GruffatH
DurandB
1989 The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R. J Virol 63 5276 5284
41. LiuQ
SummersWC
1992 Identification of the 12-O-tetradecanoylphorbol-13-acetate-responsive enhancer of the MS gene of the Epstein-Barr virus. J Biol Chem 267 12049 12054
42. KenneyS
Holley-GuthrieE
MarEC
SmithM
1989 The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J Virol 63 3878 3883
43. RyderSP
RechtMI
WilliamsonJR
2008 Quantitative analysis of protein-RNA interactions by gel mobility shift. Methods Mol Biol 488 99 115
44. LehmanAM
EllwoodKB
MiddletonBE
CareyM
1998 Compensatory energetic relationships between upstream activators and the RNA polymerase II general transcription machinery. J Biol Chem 273 932 939
45. ChytilM
PetersonBR
ErlansonDA
VerdineGL
1998 The orientation of the AP-1 heterodimer on DNA strongly affects transcriptional potency. Proc Natl Acad Sci U S A 95 14076 14081
46. WilliamsJS
AndrisaniOM
1995 The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc Natl Acad Sci U S A 92 3819 3823
47. WenW
IwakiriD
YamamotoK
MaruoS
KandaT
2007 Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J Virol 81 1037 1042
48. AdamsonAL
KenneyS
1999 The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J Virol 73 6551 6558
49. ZerbyD
ChenCJ
PoonE
LeeD
ShiekhattarR
1999 The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus. Mol Cell Biol 19 1617 1626
50. GuentherMG
LevineSS
BoyerLA
JaenischR
YoungRA
2007 A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130 77 88
51. MellorJ
DudekP
ClynesD
2008 A glimpse into the epigenetic landscape of gene regulation. Curr Opin Genet Dev 18 116 122
52. MikkelsenTS
KuM
JaffeDB
IssacB
LiebermanE
2007 Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 553 560
53. PetosaC
MorandP
BaudinF
MoulinM
ArteroJB
2006 Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol Cell 21 565 572
54. LeonardDA
KerppolaTK
1998 DNA bending determines Fos-Jun heterodimer orientation. Nat Struct Biol 5 877 881
55. Ramirez-CarrozziV
KerppolaT
2003 Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1. Mol Cell Biol 23 1737 1749
56. GloverJN
HarrisonSC
1995 Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373 257 261
57. GloecknerCJ
BoldtK
SchumacherA
RoepmanR
UeffingM
2007 A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7 4228 4234
58. LiH
RuanJ
DurbinR
2008 Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18 1851 1858
59. BaileyTL
BodenM
BuskeFA
FrithM
GrantCE
2009 MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res 37 W202 8
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 9
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens
- The Length of Vesicular Stomatitis Virus Particles Dictates a Need for Actin Assembly during Clathrin-Dependent Endocytosis
- Inhibition of TIR Domain Signaling by TcpC: MyD88-Dependent and Independent Effects on Virulence
- Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes